Skip to main content

Pathogenesis of Bacterial Meningitis

Relationship to Opsonic Activity in Normal Cerebrospinal Fluid

  • Chapter
Neurobiology of Cerebrospinal Fluid 2
  • 206 Accesses

Abstract

In the preantimicrobial era, acute pyogenic meningitis was almost always fatal and neurological sequelae were common in most survivors.7,18 Despite major advances in antimicrobial chemotherapy, rapid diagnostic techniques, and the development of effective pneumococcal and meningococcal vaccines, the annual incidence and mortality rates for bacterial meningitis have remained essentially unchanged over the past decade. In 1978, more than 4000 cases of acute bacterial meningitis were reported to the Centers for Disease Control, representing a rate of 0.19 cases/ 100,000 population with an overall case-fatality rate of 13.6%.23

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agbayani, M. M., Braun, J., Chang, C. T., Glass, L., Evans, H. E.: Effect of CSF on bacterial growth. Arch. Neurol. 38: 43–45, 1981.

    Article  Google Scholar 

  2. Austrian, R.: Vaccines of pneumococcal capsular polysaccharides and the prevention of pneumococcal pneumonia. In Beers, R. F., Jr., Bassett, E. G. (eds.): The Role of Immunological Factors in Infectious, Allergic, and Autoimmune Processes. New York, Raven Press, 1976, pp. 79–89.

    Google Scholar 

  3. Bratlid, D., Bovre, K.: Bacteriolytic activity of normal and pathological cerebrospinal fluid. Acta. Pathol. Microbiol. Scand. 85: 21–25, 1977.

    Google Scholar 

  4. Cova, J. L., Propp, R. P., Barron, K. D.: Quantitative relationships of the fourth complement component in human cerebrospinal fluid. J. Lab. Clin. Med. 89: 615–621, 1977.

    Google Scholar 

  5. Dacey, R. G., Scheld, W. M., Winn, H. R., Jane, J. A., Sande, M. A.: Bacterial meningitis: Selected aspects of cerebrospinal fluid pathophysiology. In Wood, J. H. (ed.): Neurobiology of Cerebrospinal Fluid 2. New York, Plenum Press, 1983, Chapter 46.

    Google Scholar 

  6. Dandy, W. E. (ed.): The Brain. New York, Harper and Row, 1969.

    Google Scholar 

  7. Feigin, R. D., Stechenberg, B. W., Chang, M. J., Dunkle, L. M., Wong, M. L., Palkes, H., Dodge, P. R., Davis, H.: Prospective evaluation of treatment of Hemophilus influenzae meningitis. J. Pediatr. 88: 542–548, 1976.

    Google Scholar 

  8. Feldman, W. E.: Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. N. Engl. J. Med. 296: 433–435, 1977.

    Article  Google Scholar 

  9. Finland, M., Barnes, M. W.: Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935–1972. J. Infect. Dis. 136: 400–415, 1977.

    Article  Google Scholar 

  10. Fossan, G. O., Larsen, J. L.: Variation of immunoglobulin G and total protein concentrations during lumbar cerebrospinal fluid collection. Eur. Neurol. 18: 140–144, 1979.

    Article  Google Scholar 

  11. Forsgren, A., Quie, P. G.: Influence of the alternate complement pathway on opsonization of several bacterial species. Infect. Immun. 10: 402–404, 1974.

    Google Scholar 

  12. Ganrot-Norlin, K.: Relative concentrations of albumin and IgG in cerebrospinal fluid in health and in acute meningitis. Scand. J. Infect. Dis. 10: 57–60, 1978.

    Google Scholar 

  13. Gill, G., Brody, M.: Cerebrospinal fluid immunoglobulins in children. Arch. Dis. Child. 54: 961–967, 1979.

    Article  Google Scholar 

  14. Greenfield, S., Sheehe, P. R., Feldman, H. A.: Meningococcal carriage in a population of “normal” families. J. Infect. Dis. 123: 67–73, 1971.

    Article  Google Scholar 

  15. Gregorious, F. K., Johnson, B. L., Stern, W. E., Brown, W. J.: Pathogenesis of hematogenous bacterial meningitis in rabbits. J. Neurosurg. 45: 561–567, 1976.

    Article  Google Scholar 

  16. Hartley, T. F., Merrill, D. A., Claman, H. N.: Quantitation of immunoglobulins in cerebrospinal fluid. Arch. Neurol. 15: 472–479, 1966.

    Article  Google Scholar 

  17. Heerema, M. S., Ein, M. E., Musher, D. M., Bradshaw, M. W., Williams, T. W., Jr.: Anaerobic bacterial meningitis. Am. J. Med. 67: 219–227, 1979.

    Article  Google Scholar 

  18. Holdaway, M. D., Turk, D. C.: Capsulated Haemophilus influenzae and respiratory tract disease. Lancet1: 358–360, 1967.

    Article  Google Scholar 

  19. Mccarthy, P. L., Grundy, G. W., Speisel, S. Z., Dolan, T. F., Jr.: Bacteremia in children: An outpatient clinical review. Pediatrics57: 861–868, 1976.

    Google Scholar 

  20. MCgowan, J. E., Barnes, M. W., Finland, M.: Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935–1972), with special reference to hospital-acquired cases. J. Infect. Dis. 132: 316–335, 1975.

    Article  Google Scholar 

  21. Metchnikoff, E.: Immunity in Infective Diseases. Translated by Binnie, F. G., London, Cambridge University Press, 1905.

    Google Scholar 

  22. Moxon, E. R., Smith, A. L., Averill, D. R., Smith, D. H.: Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J. Infect. Dis. 129: 154–162, 1974.

    Google Scholar 

  23. Moxon, E. R., Murphy, P. A.: Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism. Proc. Natl. Acad. Sci. U.S.A. 75: 1534–1536, 1978.

    Google Scholar 

  24. Moxon, E. R., Ostrow, P. T.: Haemophilus influenzae meningitis in infant rats: Role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid. J. Infect. Dis. 135: 303–307, 1977.

    Google Scholar 

  25. National Communicable Disease Center: Surveillance Summary: Bacterial meningitis and meningococcemia—United States, 1978. Morbid. Mortal. Weekly Rep. 28: 277–279, 1979.

    Google Scholar 

  26. Norden, C.: Prevalence of bactericidal antibodies to Hemophilus influenzae, type b. J. Infect. Dis. 130: 489–494, 1974.

    Article  Google Scholar 

  27. Norrby, R.: Penetration of antimicrobial agents into cerebrospinal fluid: Pharmacokinetic and clinical aspects, In Wood, J. H. (ed.): Neurobiology of Cerebrospinal Fluid 1. New York, Plenum Press, 1980, pp. 449–463.

    Chapter  Google Scholar 

  28. Peterson, P. K., Kim, Y., Schmeling, D., Lindemann, M., Verhoef, J., Quie, P. G.: Complement-mediated phagocytosis of Pseudomonas aeruginosa. J. Lab. Clin. Med. 92: 883–894, 1978.

    Google Scholar 

  29. Peterson, P. K., Wilkinson, B. J., Schmeling, D., Quie, P. G.: Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect. Immun. 19: 943–949, 1978.

    Google Scholar 

  30. Petz, L. D., Sharp, G. C., Cooper, N. R., Irvin, W. S.: Serum and cerebrospinal fluid complement and serum auto-antibodies in systemic lupus erythematosus. Medicine (Baltimore)50: 259–275, 1971.

    Article  Google Scholar 

  31. Quie, P. G., Mills, E. L., Holmes, B.: Molecular events during phagocytosis by human neutrophils. In Brown, E. B. (ed.): Progress in Hematology, Vol. X. New York, Grune and Stratton, 1977, pp. 193–210.

    Google Scholar 

  32. Robbins, J., Schneerson, R., Argaman, M., Zeev, T. H.: Hemophilus influenzae type b: Disease and immunity in humans. Ann. Intern. Med. 78: 259–269, 1973.

    Google Scholar 

  33. Shin, H. S., Smith, M. R., Wood, W. B.: Heat-labile opsonins to pneumococcus. II. Involvement of C3 and C5. J. Exp. Med. 130: 1229–1241, 1969.

    Article  Google Scholar 

  34. Simberkoff, M. S., Moldover, N. H., Rahal, J. J., Jr.: Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids: A regional host defense deficiency. J. Lab. Clin. Med. 95: 362–372, 1980.

    Google Scholar 

  35. Stossel, T. P.: Phagocytosis. N. Engl. J. Med. 290: 774–780, 1974.

    Article  Google Scholar 

  36. Suhs, R. H., Feldman, H. A.: Pneumococcal types detected in throat cultures from a population of “normal” families. Am. J. Med. Sci. 250: 424–427, 1965.

    Article  Google Scholar 

  37. Swartz, M. N., Dodge, P. R.: Bacterial meningitis: A review of selected aspects. N. Engl. J. Med. 272: 725–731, 779-787, 842-848, 898-902, 954-960, 1003-1010, 1965.

    Article  Google Scholar 

  38. Tofte, R. W., Peterson, P. K., Kim, Y., Quie, P. G.: Influence of serum concentration on opsonization by the classical and alternative complement pathways. Infect. Immun. 27: 693–696, 1980.

    Google Scholar 

  39. Tofte, R. W., Peterson, P. K., Schmeling, D., Bracke, J., Kim, Y., Quie, P. G.: Opsonization of four Bacteroides species: Role of the classical complement pathway and immunoglobulin. Infect. Immun. 27: 784–792, 1980.

    Google Scholar 

  40. Tofte, R. W., Peterson, P. K., Kim, Y., Quie, P. G.: Opsonic activity of normal human cerebrospinal fluid for selected bacterial species. Infect. Immun. 26: 1093–1098, 1979.

    Google Scholar 

  41. Verbruch, H. A., Van Dijk, W. C., Peters, R., Van Der Tol, M. E., Peterson, P. K., Verhoef, J.: Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways: A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2. Immunology36: 391–397, 1979.

    Google Scholar 

  42. Verhoef, J., Peterson, P. K., Kim, Y., Sabath, L. D., Quie, P. G.: Opsonic requirements for staphylococcal phagocytosis: Heterogeneity among strains. Immunology33: 191–197, 1977.

    Google Scholar 

  43. Williams, R. C., Jr., Quie, P. G.: Opsonic activity of agammaglobulinemic human sera. J. Immunol. 106: 51–55, 1971.

    Google Scholar 

  44. Wood, J. H.: Physiological neurochemistry of cerebrospinal fluid. In Lajtha, A. (ed.): Handbook of Neurochemistry, Vol. 1, 2nd ed. New York, Plenum Press, 1982, pp. 415–487.

    Google Scholar 

  45. Wood, J. H.: Physiology, pharmacology, and dynamics of cerebrospinal fluid. In Wood, J. H. (ed.): Neurobiology of Cerebrospinal Fluid 1. Plenum Press, 1980, pp. 1–16.

    Google Scholar 

  46. Wright, A. E., Douglas, S. R.: Further observations on the role of the blood fluids in connection with phagocytosis. Proc. R. Soc. London73: 128–142, 1904.

    Article  Google Scholar 

  47. Young, L. S., Laforce, F. M., Head, J. J., Feely, J. C., Bennett, J. V.: A simultaneous outbreak of meningococcal and influenza infections. N. Engl. J. Med. 287: 5–9, 1972.

    Article  Google Scholar 

  48. Zwahlen, A., Nydegger, U. E., Viudaux, P., Lambert, P.-H., Waldvogel, F. A.: Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: Early response during bacterial meningitis. J. Infect. Dis. 145: 635–646, 1982.

    Article  Google Scholar 

  49. Zwalen, A., Nydeger, U., Waldvogel, F. A., Lambert, P. H.: Complement mediated opsonic activity of cerebrospinal fluid in acute meningitis. Clin. Res. 27:361A, 1979.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Plenum Press, New York

About this chapter

Cite this chapter

Tofte, R.W. (1983). Pathogenesis of Bacterial Meningitis. In: Wood, J.H. (eds) Neurobiology of Cerebrospinal Fluid 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9269-3_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9269-3_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9271-6

  • Online ISBN: 978-1-4615-9269-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics